Hepion Pharmaceuticals, Inc. (CTRVP) — DEFA14A Filings
All DEFA14A filings from Hepion Pharmaceuticals, Inc.. Browse 2 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (2)
-
Hepion Pharma Files Proxy Materials for P2B001 Presentation
— Dec 5, 2024 Risk: low
Hepion Pharmaceuticals, Inc. filed a Definitive Additional Materials (DEFA14A) on December 5, 2024, related to a poster presentation on their drug candidate P2B -
Hepion Pharma Urges Shareholder Support in DEFA14A Filing
— Dec 2, 2024 Risk: low
Hepion Pharmaceuticals, Inc. (HEPN) filed a DEFA14A on December 2, 2024, announcing a letter to shareholders. The letter urges support for the company's proposa
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX